IMPACT BIOMEDICAL INC. (IBO) Insider Trading & SEC Filings
Last SEC filing
IMPACT BIOMEDICAL INC. (IBO) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every IBO SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. trades under the ticker IBO. InsiderAlpha tracks 9 primary SEC Form 4 filings from 5 reporting insiders for IBO since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0001834105 |
|---|
Recent IBO Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Todd D. Macko | Chief Financial Officer | S - Open-market sale | 43.4K | $0.56 | $24K | SEC | |
| Todd D. Macko | Chief Financial Officer | S - Open-market sale | 1.6K | $0.60 | $961 | SEC | |
| Jason Grady | Director | S - Open-market sale | 50.0K | $0.65 | $33K | SEC | |
| DSS, INC. | 10% Owner | S - Open-market sale | 45.4K | $0.54 | $25K | SEC | |
| DSS, INC. | 10% Owner | S - Open-market sale | 115.6K | $0.55 | $63K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 180.0K | $0.96 | $173K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 273.3K | $0.78 | $213K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 351.6K | $0.49 | $174K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 351.6K | $0.58 | $204K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 200.0K | $0.67 | $135K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 300.0K | $0.58 | $174K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 2.3K | $0.67 | $2K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 382.4K | $0.58 | $223K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 400.0K | $0.98 | $393K | SEC | |
| Heng Fai Ambrose Chan | Director | S - Open-market sale | 650.0K | $1.45 | $941K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for IMPACT BIOMEDICAL INC. (IBO). Updated in real time as new filings are submitted to the SEC.
Recent IBO Form 8-K Material Events
- - Item 1.01, 9.01 · Acquisition · neutral [SEC]
Impact BioMedical Inc. entered into Amendment No. 1 to its previously disclosed Merger and Share Exchange Agreement dated June 21, 2025. The amendment modifies the share consideration structure by adding 128,000 PubCo ordinary shares to be issued to DSS, Inc. in two batches (53,0
Recent IBO Form 144 Notices of Proposed Sale
- - - [SEC]
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
Recent Insider Filings
- - Todd D. Macko (Chief Financial Officer)
- - Jason Grady (Director)
- - DSS, INC. (10% Owner)
- - Heng Fai Ambrose Chan (Director)
- - Heng Fai Ambrose Chan (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IBO insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
IBO Insider Trading - FAQ
- What is the latest insider trade for IBO?
- IMPACT BIOMEDICAL INC. (IBO) had 0 insider filings in the last 90 days, with the most recent on 2026-03-31. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying IBO stock?
- 0 insider purchases of IBO were filed in the last 90 days.
- How many insiders are selling IBO stock?
- 0 insider sales of IBO were filed in the last 90 days.
- Where can I see IBO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks IBO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ICCM IceCure Medical Ltd.
- $ICD Independence Contract Drilling, Inc.
- $ICON Icon Energy Corp
- $IDACU Iron Dome Acquisition I Corp.
- $IEAG Infinite Eagle Acquisition Corp.
- $IGACU Invest Green Acquisition Corp
- $ILXP ECOMINAS CORP.
- $IMC IMC Rare Earths Ltd
- $IMSR Terrestrial Energy Inc. /DE/
- $INAI Invea Therapeutics, Inc
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live IBO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.